BioSpectrum India on MSN
India 2030: Who supplies the next 10 million?
India’s diabetes market is entering a defining decade. The withdrawal of selected human insulin pens by Novo Nordisk, the ...
Swiss startup Atlas Bio raises $12.5M to build in silico clinical trials and tackle the 70% Phase II failure rate. What is ...
Visteon said Chief Financial Officer Jerome Rouquet will leave the company effective Nov. 30 to pursue other opportunities. Chief Accounting Officer Colleen Myers, 51, was appointed interim ...
Cipher found four previously unknown vulnerabilities in EPICS in 3 hours and 49 minutes. One could allow remote code execution on systems used to control particle accelerators and fusion experiments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results